日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection.

评估基于树突状细胞的免疫疗法 AGS-004 和伏立诺他治疗持续性 HIV-1 感染的影响

Gay Cynthia L, Kuruc Joann D, Falcinelli Shane D, Warren Joanna A, Reifeis Sarah A, Kirchherr Jennifer L, James Katherine S, Dewey Morgan G, Helms Alyson, Allard Brigitte, Stuelke Erin, Gamble Alicia, Plachco Ana, Gorelick Robert J, Eron Joseph J, Hudgens Michael, Garrido Carolina, Goonetilleke Nilu, DeBenedette Mark A, Tcherepanova Irina Y, Nicolette Charles A, Archin Nancie M, Margolis David M